Hyperbaric oxygen therapy for the brain fog of long COVID

Not Applicable

Withdrawn

• Conditions: Codes for special purposes

• Registration Number: KCT0007654
• Lead Sponsor: Myongji Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-11-08
• Last Update Posted: 28 November 2022

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1) More than 12 weeks have passed since the date of COVID-19 confirmed by RT-PCR
2) Brain fog symptoms occurred within 6 months of being confirmed by the COVID-19 and have persisted until now.
3) Age between 30 ~70 yrs
4) Proficient in Korean
5) A person who has consented to this participation and prepared a written consent before the start of the human application test

Exclusion Criteria

1) History of head trauma accompanied by loss of consciousness, stroke, epilepsy, dementia and other brain diseases
2) Currently undergoing cancer treatment (surgery, chemotherapy, radiation)
3) Serious heart disease (myocardial infarction, angina pectoris, severe arrhythmia), lung disease (chronic obstructive pulmonary disease, emphysema, asthma, pneumothorax), and other serious medical conditions
4) Currently alcoholic or drug dependent, or have been diagnosed with schizophrenia.
5) Otitis media, severe rhinitis, and problems with normal ear pressure control
6) A person judged by the investigator to be inappropriate for this human application test

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changes in T score of 5 items of cognitive test;Changes in the total score of 5 survey items;Results of immune marker (ESR, CRP, cytokine assay (IL-2, IL-6, IL-8, IL-10))

Secondary Outcome Measures

Name	Time	Method
Results of immune marker (ESR, CRP, cytokine assay (IL-2, IL-6, IL-8, IL-10))